default author photo

Wangting Li

Government of the People's Republic of China - Xijing Hospital

Xi’an, 710032

China

  • Government of the People's Republic of China - Xijing Hospital

SCHOLARLY PAPERS

1

DOWNLOADS

38

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Erzhi Pill Protects Against Hepatic Ischemia/Reperfusion Injury Through Activating PI3K/Akt/SIRT1 Signaling Pathway

Number of pages: 29 Posted: 11 Apr 2023
Wangting Li, Haixia Chen, Zhengrong Li, Dongmei Hu, Yuwen Liu, Shaojie Huang, Sijun Hu, Jinyi Chen, Xingru Tao, Yue Chen, Fei Mu, Jialin Duan and Jingwen Wang
Government of the People's Republic of China - Xijing Hospital, Government of the People's Republic of China - Xijing Hospital, Northwestern Polytechnic University (NPU) - Institute of Medical Research, Government of the People's Republic of China - Xijing Hospital, Northwestern Polytechnic University (NPU) - Institute of Medical Research, Government of the People's Republic of China - Xijing Hospital, Northwestern Polytechnic University (NPU) - Institute of Medical Research, Government of the People's Republic of China - Xijing Hospital, Government of the People's Republic of China - Xijing Hospital, Government of the People's Republic of China - Xijing Hospital, Government of the People's Republic of China - Xijing Hospital, Northwestern Polytechnic University (NPU) - Institute of Medical Research and Government of the People's Republic of China - Xijing Hospital
Downloads 38 (1,209,354)

Abstract:

Loading...

Erzhi pill, hepatic ischemia-reperfusion injury, PI3K/AKT, SIRT1.